Zentalis Pharmaceuticals, Inc. (ZNTL)

CIK 1725160 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Zentalis Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 19, 202640001213900-26-091823
Aug 19, 2026SCHEDULE 13G/A0001213900-26-091824
Aug 14, 20268-K0001628280-26-057112
Aug 14, 2026424B50001628280-26-057108
Aug 13, 2026SCHEDULE 13G/A0000312069-26-000217
Aug 13, 2026424B50001628280-26-056729
Aug 6, 20268-K0001725160-26-000061
Aug 6, 202610-Q0001725160-26-000062
Jul 30, 2026SCHEDULE 13G0002012383-26-003135
Jun 18, 202640001843119-26-000003
Jun 18, 202640001356256-26-000005
Jun 18, 202640001701440-26-000004
Jun 18, 202640001808098-26-000003
Jun 18, 202640001838042-26-000003
Jun 18, 20268-K0001725160-26-000052
May 27, 20268-K0001725160-26-000049
May 27, 202640002018966-26-000005
May 27, 2026DEFA14A0001725160-26-000050
May 27, 202630002018966-26-000004
May 21, 20268-K0001725160-26-000045
May 12, 20268-K0001725160-26-000041
May 12, 202610-Q0001725160-26-000042
May 5, 20268-K0001725160-26-000033
Apr 30, 2026ARS0001725160-26-000026
Apr 30, 2026DEFA14A0001725160-26-000028